Triple-action drug retatrutide delivers major weight loss for people with diabetes, Phase III trial finds

A recent Phase III clinical trial has found that a triple-action drug, retatrutide, delivers major weight loss for people with diabetes.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.